UDENYCA
NDC 70114-130, pegfilgrastim-cbqv, injection, solution, from Coherus Oncology, Inc..
- Product NDC
- 70114-130
- Status
- Listed
- Labeler
- Coherus Oncology, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761039
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70114-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEGFILGRASTIM6 mg/.6mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70114-130-01 | 70114013001 | 1 SYRINGE in 1 CARTON (70114-130-01) / .6 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a8c290ee-b699-4395-a596-1453d4a4b4ebMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70114-130
Use it
Look up 70114-130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70114-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70114-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.